Example: Heart Attack

Search clinical trials for: Adrenergic beta-2 Receptor Agonists

Total 983 results

NCT01676987

Completed

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Conditions: Asthma
NCT03565302

Recruiting

Beta2-adrenergic Agonism and Muscle Remodelling

Conditions: Hypertrophy; Physiologic Hypertrophy; Physical Activity
NCT00567476

Completed

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

Conditions: Asthma
NCT03449056

Recruiting

High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Conditions: Chronic Obstructive Pulmonary Disease; High-flow Nasal Cannula
NCT02885636

Completed

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial

Conditions: Congestive Heart Failure; Heart Failure, Left-Sided; Left-Sided Heart Failure
NCT01209715

Withdrawn

Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD

Conditions: COPD
NCT01576718

Completed

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Conditions: Asthma
NCT01479621

Completed

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Conditions: Asthma
NCT04503460

Not yet recruiting

Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

Conditions: Asthma
NCT01355991

Unknown status

Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI

Conditions: Spinal Cord Injury
NCT04137029

Recruiting

Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers

Conditions: Health, Subjective; Hyperreactivity, Bronchial
NCT02914652

Completed

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.

Conditions: Ventricular Septal Defect
NCT00706446

Terminated

The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations

Conditions: Asthma
NCT01944033

Completed

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

Conditions: Acute Exacerbation of Chronic Obstructive Airways Disease
NCT03914638

Recruiting

Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis

Conditions: Myasthenia Gravis
NCT01437995

Completed

Long-acting Beta Agonist Step Down Study

Conditions: Asthma
NCT00521222

Unknown status

Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes

Conditions: Asthma
NCT00950794

Completed

Study of Salmeterol (SN408D) for Adult Asthma

Conditions: Asthma; Bronchial Asthma
NCT04655170

Not yet recruiting

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD

Conditions: COPD Exacerbation
NCT02170532

Completed

Aerosolized Beta-Agonist Isomers in Asthma

Conditions: Asthma
NCT00974051

Completed

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Conditions: Type 1 Diabetes
NCT01312961

Completed

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Conditions: Asthma
NCT01110200

Completed

Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study

Conditions: Pulmonary Disease, Chronic Obstructive
NCT02094274

Completed

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

Conditions: Asthma
NCT01447069

Unknown status

Use of Beta-agonists in Stable Severe Congestive Heart Failure

Conditions: Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy; Heart Failure